Russia’s Medtech Revolution

Russia’s health care authorities are building a modern system to meet the needs of a growing population and better regulation of entry into the $6 billion medical device market is an important element of this wider aim. Alexandra Tretiakova, executive director of Russia’s International Medical Device Manufacturers Association, weighs in on how the complex new set of rules will impact the medtech industry.

Imperfectly clumped together with other BRICs – a term that is now falling rapidly out of favor as the differences between these four “founder” emerging economies become more defined – Russia is something of a conundrum. It is an emerging market, with an aging population, a chronic disease burden, and low life expectancies. But 68% of its population of 143 million is classified as middle class (interestingly, the population rose in 2013 for the first time since the collapse of the Soviet Union), it has a highly educated workforce, and its GDP is among the highest of the emerging markets.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from In Vivo